House Medicare Bill Expands Competitive Bidding To DME Infusion Products

Device industry concerns that an expanded Medicare competitive bidding program would eventually include new, high-end technologies may be alleviated by language in the "Medicare Prescription Drug & Modernization Act" of 2003, which specifically excludes Class III devices

More from Archive

More from Medtech Insight